Efficacy evaluation of complement inhibitors and clinical follow-up of paroxysmal nocturnal hemoglobinuriaHAN Bing554-558
Extravascular hemolysis and breakthrough hemolysis of paroxysmal nocturnal hemoglobinuriaHE Guang-sheng, QIN Cheng-tao559-563
Management of common complications and comorbidities in paroxysmal nocturnal hemoglobinuriaJIA Jin-song564-569,587
Cloning evolution mechanism of paroxysmal nocturnal hemoglobinuriaZHOU Rui-qing, WANG Shun-qing570-575
Expert consensus on insomnia treated by cognitive behavioral therapy combined with drug or physical therapySleep Group of Neurology Branch of Chinese Medical Doctor Association, Research Group of National Key R&D Plan(2022YFC2503900)of Ministry of Science and Technology, WANG Hong-xing, SU Chang-jun576-587
Interpret of Preferred Reporting Items for Microbiotherapy Guidelines(PRIM 2024)ZHANG Zu-lun, WU Xia, CUI Bo-ta, ZHANG Fa-ming588-592
Analysis of persistent anemia following Eculizumab treatment in paroxysmal nocturnal hemoglobinuria patients with high disease-activity statusZHANG Ting, YUAN Ying-ying, QIN Cheng-tao, MA Yong-chao, GONG Yue-min, ZHANG Ya-wen, FANG Bao-zhi, LYU Ming-en, XU Jin-ge, SHI Xiao-feng, HE Guang-sheng, SHI Jin-ning593-599,605
Analysis of hematology ICU treatment of patients with hematological malignancies complicated with critical COVID-19LI Qian, XIE Yan, LIANG Pei-qi, LIU Zi-yi, WANG Dong, GAO Meng, LI Wei-yang, WANG Ying, WU De-pei, FU Jian-hong600-605